Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001764454-19-000001
Filing Date
2019-01-11
Accepted
2019-01-11 10:02:40
Documents
1
Effectiveness Date
2019-01-11
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 5610
  Complete submission text file 0001764454-19-000001.txt   6643
Mailing Address 212 W 10TH ST, SUITE A480 INDIANAPOLIS IN 46202
Business Address 212 W 10TH ST, SUITE A480 INDIANAPOLIS IN 46202 317-612-4672
NERx Biosciences, Inc. (Filer) CIK: 0001764454 (see all company filings)

EIN.: 271318867 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-330243 | Film No.: 19521575